article thumbnail

Time for a NICE change

pharmaphorum

This article appears in our digital magazine Deep Dive: Market Access 2021. And anyone interested in a game of policy bingo will be able to mark off all the important policy documents and every agency too. Leela Barham takes stock. Read below for a preview: NICE has never stood still since it started its work in 1999.

article thumbnail

FIP expert group issues advice for pharmacists on COVID-19 tests

Pharma Mirror

The Hague — To help pharmacists advise people on COVID-19 tests, the International Pharmaceutical Federation (FIP), has today issued a guidance document. The document covers how different types of diagnostic test work and the interpretation of results. COVID-19 tests are available from many different manufacturers and the.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bob Tribe, ISPE Asia-Pacific Regulatory Advisor, Retires

ISPE

Bob also initiated an agreement under which ISPE’s Guidance Documents are made available to PIC/S and WHO inspectors, which is still in place today. Most recently he assisted the regulatory authorities of Saudi Arabia, Russia, China, Jordan, and Philippines in the process to attain PIC/S membership.

article thumbnail

ISPE Briefs: ISPE Initiatives Provide Guidance on Medicines Supply

ISPE

We have 19 committees, councils, and working groups that are doing incredible work bringing visibility to the industry’s regulatory challenges and developing solutions that are delivered through ISPE content outlets: webinars, PE magazine articles, iSpeak blog posts, training materials, conference sessions, and ISPE Guidance Documents.

article thumbnail

Gene editing: beyond the hype

pharmaphorum

On top of this, there are the well-documented manufacturing challenges that come with such a new field. “I George Underwood is pharmaphorum’s Deep Dive magazine editor. I think we’ve all learnt that we need to spend more time earlier on in developing the industrial processes,” Macrae says. About the author.

article thumbnail

How will NICE fare in a post-Brexit world?

pharmaphorum

This article appears in our digital magazine, Deep Dive: Market Access 2021. It is still working collaboratively with global health system partners, and more particularly with the MHRA, to design a streamlined process for licensing and evaluating new medicines.”. • Read the full article in pharmaphorum’s Deep Dive digital magazine.

article thumbnail

COVID heralds a faster future for drug development (if stakeholders can collaborate)

pharmaphorum

When we submitted our clinical trial documents, we got feedback within a few days, which sped everything up,” he said. “If George Underwood is the editor for pharmaphorum’s Deep Dive digital magazine. About the author. The post COVID heralds a faster future for drug development (if stakeholders can collaborate) appeared first on.